Clinical Research In India Expected To Be $254 Million Industry By 2010
This article was originally published in PharmAsia News
India expects its clinical research market to be a $254 million industry by 2010 by riding a current 84 percent growth rate. The Clinical Research Institute says the country's pharmaceutical industry is growing at the rate of 11 percent, far behind the growth rate in clinical research work. Foreign drug makers invested nearly $13 million in Indian clinical research in 2005-2006. (Click here for more
You may also be interested in...
A proposed rule released last month by the US Department of Health and Human Services is the Trump administration’s “latest attempt to sabotage HHS programs,” wrote Jessica Schubel, a senior policy analyst for the Center on Budget and Policy Priorities. See what the policy expert said about it in her blog post here.
Helped by a hefty financing earlier this year, Bukwang subsidiary Contera Pharma is poised to speed ongoing multinational Phase II trials with its lead asset for Parkinson’s-associated dyskinesia by hiring CNS experts as new top executives, as the Korean firm looks to take it public in ground-breaking move.
White House and HHS are increasing pressure on FDA Commissioner Hahn to clear Pfizer and Moderna’s COVID-19 vaccines as soon as possible – potentially skirting the advisory committee process. The move is leaving a last-minute political stain on a regulatory process the FDA fought hard to keep science-based and could foster a new wave of vaccine hesitancy amongst the American public.